Pitfalls in Urine Cytology: A Case of Fumarate Hydratase-Deficient Renal Cell Carcinoma Initially Diagnosed as High-Grade Urothelial Carcinoma

被引:0
|
作者
Cheng, Kai [1 ]
Zhang, Xuelian [2 ]
Zhou, Xiaodie [1 ]
Wang, Xiaotong [1 ]
Bao, Wei [1 ]
Rao, Qiu [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Affiliated Hosp, Dept Pathol,Jinling Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing King Med Med Lab Co Ltd, Dept Pathol, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
cytomorphologic features; FH-deficient RCC; liquid-based; Papanicolaou staining; urinary cytology; KIDNEY;
D O I
10.1002/dc.25409
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare, aggressive, hereditary subtype of renal cancer that requires careful diagnostic considerations. We report a case of a 33-year-old Asian woman who presented with a 20-day history of hematuria. Imaging studies revealed a solid tumor in the lower pole of the right kidney with lymph node metastases. Urinary cytology revealed benign squamous cells, inflammatory cells, and atypical epithelial cells, suggestive of high-grade urothelial carcinoma. Following a right nephrectomy, the tumor displayed papillary structures composed of cells exhibiting atypical, elongated nuclei with eosinophilic nucleoli and peripheral halos. Immunohistochemical staining demonstrated negative FH expression. Genetic analysis identified a somatic missense mutation in the FH gene, confirming the diagnosis of FH-deficient RCC. This case highlights the importance of integrating cytological, histological, and genetic analyses for accurate diagnosis of FH-deficient RCC.
引用
收藏
页码:E11 / E16
页数:6
相关论文
共 50 条
  • [11] Response to systemic therapy in fumarate hydratase-deficient renal cell carcinoma
    Carril-Ajuria, Lucia
    Colomba, Emeline
    Cerbone, Luigi
    Romero-Ferreiro, Carmen
    Crouzet, Laurence
    Laguerre, Brigitte
    Thibault, Constance
    Vicier, Cecile
    de Velasco, Guillermo
    Flechon, Aude
    Saldana, Carolina
    Benusiglio, Patrick R.
    Bressac-de Paillerets, Brigitte
    Guillaud-Bataille, Marine
    Gaignard, Pauline
    Scoazec, Jean-Yves
    Richard, Stephane
    Caron, Olivier
    Escudier, Bernard
    Albiges, Laurence
    EUROPEAN JOURNAL OF CANCER, 2021, 151 : 106 - 114
  • [12] Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma
    Sun, Guangxi
    Zhang, Xingming
    Liang, Jiayu
    Pan, Xiuyi
    Zhu, Sha
    Liu, Zhenhua
    Armstrong, Cameron M.
    Chen, Jianhui
    Lin, Wei
    Liao, Banghua
    Lin, Tianhai
    Huang, Rui
    Zhang, Mengni
    Zheng, Linmao
    Yin, Xiaoxue
    Nie, Ling
    Shen, Pengfei
    Zhao, Jinge
    Zhang, Haoran
    Dai, Jindong
    Shen, Yali
    Li, Zhiping
    Liu, Jiyan
    Chen, Junru
    Liu, Jiandong
    Wang, Zhipeng
    Zhu, Xudong
    Ni, Yuchao
    Qin, Dan
    Yang, Ling
    Chen, Yuntian
    Wei, Qiang
    Li, Xiang
    Zhou, Qiao
    Huang, Haojie
    Yao, Jin
    Chen, Ni
    Zeng, Hao
    CLINICAL CANCER RESEARCH, 2021, 27 (06) : 1734 - 1743
  • [13] The value of blood oxygenation level-dependent (BOLD) MR in differentiation of fumarate hydratase-deficient renal cell carcinoma and high-grade clear cell renal cell carcinoma
    Zhao, F.
    He, C.
    Chen, Y.
    Xu, H.
    Liu, H.
    Xu, N.
    Sun, G.
    Yao, J.
    Zeng, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1523 - S1523
  • [14] Hereditary leiomyomatosis and renal cell carcinoma/fumarate hydratase-deficient renal cell carcinoma: two primaries in one
    Storey, Benjamin
    Shugg, Nathan
    Grant, Alexander
    ANZ JOURNAL OF SURGERY, 2020, 90 (04) : E93 - E94
  • [15] Fumarate Hydratase-Deficient Renal Cell Carcinoma: Aspiration and Effusion Cytologic Features
    Shyu, Irene
    Wang, Xiaoyan
    Robila, Valentina
    Mehra, Rohit
    McHugh, Jonathan
    Chen, Ying-Bei
    Udager, Aaron
    Gill, Anthony
    Cheng, Liang
    Amin, Mahul
    Smith, Steven
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S39 - S40
  • [16] Fumarate hydratase-deficient renal cell carcinoma in extended remission with bevacizumab and erlotinib
    Tomar, Shubham
    Kashyap, Lakhan
    Kapoor, Akhil
    ECANCERMEDICALSCIENCE, 2022, 16
  • [17] Fumarate hydratase-deficient renal cell carcinoma: an oncology care institutional experience
    Kamboj, Meenakshi
    Gupta, Gurudutt
    Pasricha, Sunil
    Mehta, Anurag
    Rawal, Sudhir
    Singh, Amitabh
    Sharma, Anila
    Durga, Garima
    Bansal, Divya
    Diwan, Himanshi
    APMIS, 2024, 132 (08) : 544 - 552
  • [18] Consensus on clinical diagnosis and treatment of fumarate hydratase-deficient renal cell carcinoma
    Yu Shen
    Zhenhua Liu
    Qiang Wei
    Wei Xue
    Holistic Integrative Oncology, 3 (1):
  • [19] Fumarate Hydratase-Deficient Renal Cell Carcinoma With Predominant Tubulocystic Features Mimics Tubulocystic Renal Cell Carcinoma
    Yang, Xiaoqun
    Liu, Yang
    Wang, Huafeng
    Xu, Yunze
    Zhang, Huizhi
    Zhao, Ming
    Luo, Xiaoqing
    Jin, Hongtao
    Xiong, Ji
    Tao, Lili
    Xu, Jiankun
    Zhou, Luting
    Li, Xiangyun
    Xu, Haimin
    Dong, Lei
    Wang, Chaofu
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (12) : 1358 - 1364
  • [20] Immunohistochemical screening for the diagnosis of succinate dehydrogenase-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma
    Trpkov, Kiril
    Siadat, Farshid
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7